We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00125970
Recruitment Status : Completed
First Posted : August 2, 2005
Last Update Posted : November 12, 2012
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)